Lacrimal Gland Measurements in Most Common Preclinical Laboratory Animals
Comparison of Baseline Levels of Biomarkers Commonly Used to Assess Drug Candidate Safety, Efficacy, and Mechanism of Action in Cynomolgus Monkeys of Cambodian, Chinese, or Cambodian-Chinese Mixed Origin Bred in a U.S.-Based Research Facility
Navigating to the Clinic: Key Aspects of Translational Pharmacology, By Bruce Morimoto
Drug development is not for the faint of heart; a twist on the Hunger Games saying, “May the odds be (n)ever in your favor,” might adequately characterizes the challenge. As scientists, however, we manage these inherent risks by establishing best practices and learning from our collective successes and failures, as well as. In this field, experience truly matters.
Why Women in STEM Matter More Than Ever: Shaping the Future of Science, by Kimberly Worley
International Day of Women and Girls in STEM, which we celebrated this month, is more than a celebration—it’s a reminder of the progress we’ve made, the challenges that still exist, and the responsibility we all share in shaping the future of science, technology, engineering, and mathematics.
First-in-Human-Enabling Toxicology Programs: Common Misconceptions by Grace M. Furman
Nomination of a clinical candidate and subsequent conduct of toxicology studies to support a first-in-human (FIH) clinical trial is an exciting milestone for sponsors! While many are highly experienced drug discovery professionals, some may have limited, or even no experience, in early clinical development, including the critical toxicology studies required to successfully support a FIH trial.